Table 1.
ID | Product name | Rasa Shastraa | Total Asb (mg.kg−1) | Total Pbb (mg.kg−1) |
---|---|---|---|---|
1 | Mahasudarshan specialty tablets | 1.4 | 8.5c | |
2 | Shilajit specialty tablets | Yes | 3.2 | 10d |
3 | Vital Lady | Yes | 2.1 | 5.5c |
4 | Worry Free | Yes | <1.0 | 7.0c |
5 | Yog-Raj Guggulu | 31d | 6d | |
6 | Commiphora mukul | <1.0 | 2.3 | |
7 | Bacopa monniera | <1.0 | 6c | |
8 | Yogaraj Guggulu | 2.2 | 2.0 | |
9 | Ezi Slim | 1.4 | 3.0c | |
10 | Shilajeet Tablets | Yes | 21d | 10d |
11 | Mahayograj Guggulu | Yes | 89 | 52,000 |
12 | Brahmi Capsules | <1.0 | 6.5c | |
13 | Amoebica | 3.8 | 11.0c | |
14 | Arogyavardhini Bati | Yes | 4.6 | 125c |
15 | Kanchanar Guggulu | <1.0 | 7.5c | |
16 | Shilajit | Yes | 1.6 | 10.5c |
17 | Lean Plus | <1.0 | 6.0c | |
18 | Neem Plus | <1.0 | 10.5c | |
19 | Prana: Breath of Life | 2.1 | 9.0c | |
20 | Bakuchi | <1.0 | 3.0c | |
21 | Brahmi | 1.1 | 6.5c | |
22 | Chairata | <1.0 | 6c | |
23 | Cold Aid | <1.0 | 5.5c | |
24 | Trifala Guggulu | 27c | 20.5c | |
25 | Heart Plus | 2.0 | 7.5c | |
26 | Jatamansi | 3.6 | 12.0c | |
27 | Kanta Kari | <1.0 | 20.5c | |
28 | Lavan Bhaskar | 3.4 | <1.0 | |
29 | Licorice — Glycyrrhiza Glabra | 1.0 | 5.5c | |
30 | Mahasudarshan | 140 d | 15d | |
31 | Praval Pisti | Yes | 27.5c | 7.5c |
32 | Prostate Rejuv | Yes | 1.2 | 11.5c |
33 | Shilajit | Yes | 12d | 1.6 |
34 | Sugar Fight | 6.4 | 7.5c | |
35 | Tagar | 2.3 | 12.0c | |
36 | Yograj Guggulu | 10.5c | 17.5c | |
37 | Ayu-Arthri-Tone | Yes | <1.0 | 63c |
38 | Ayu-Hemoridi-Tone | Yes | 7.5 | 3.9 |
39 | Ayu-Leuko-Tone | Yes | 2.6 | 33c |
40 | Ayu-Nephro-Tone | Yes | <1.0 | 340c |
41 | AyurRelief™ | <1.0 | 5.5c | |
42 | GlucoRite™ | 1.8 | 6.0c |
Products were classified as Rasa Shastra medicines (elaborately prepared compounds combining herbs with metals, minerals, and gems) by an Indian-trained Ayurvedic physician.
Unless otherwise noted, results were determined by aqua regia-ICP methods.
XRF results, previously published with significant figures as reported in Saper et al. (2008).
XRF results, reported for the first time in the present study.